Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) mUsefulness and limitations in "clinical reality"— -231 cases of pancreatic lesions -It’s cheap and useful, can detect lesions as small as 7mm and by looking at them in high resolution, Doctors can differentiate between pancreatitis and pancreatic cancer. It is feasible to use it as a differential diagnosis tool, however more research needs to be done. -However, when looking at sensitivity and specificity on page 7, EUS seems to be the better bet -Not to mention, each time one gets a PET scan, they are exposed to radiation. -“As for false-positive cases, active and chronic pancreatitis and autoimmune pancreatitis sometimes show high FDG accumulation and mimic pancreatic cancer with a shape of focal uptake.” -Document from 2003, things have changed in 7 years. -FDG in this study stands for fluorine-18 fluorodeoxyglucose -fluorine-18 fluorodeoxyglucose goes into the cytosol of a cell and if overexpression of GLUTs (glucose transporter proteins) is present, pancreatic cancer can be detected. -The FDG gets trapped in malignant tumor cells when it is phosphorylated (goes through the process of glycolysis—which is part of the energy production cycle of a cell). -Average Sensitivity- 90% -Average Specificity- 81% -No Medicare reimbursement for PET scans for pancreatic cancer, why make the old people pay so much for a scan that Medicare won’t help with? -After reading the entire article, PET should not be used for diagnostics, but maybe for monitoring once pancreatitis or pancreatic cancer has been identified.